Mulligan RC. The basic science of gene therapy. Science.1993;260:926-932.
Millennium review. Gene Ther. 2000;7:2-34, 89-125.
Fuchs E, Segre JA. Stem cells: a new lease on life. Cell.2000;100:143-155.
Gage FH. Mammalian neural stem cells. Science.2000;287:1433-1438.
Weissman IL. Translating stem and progenitor cell biology to the clinic: barriers
and opportunities. Science.2000;287:1442-1446.
Knowles MR, Hohneker KW, Zhou Z.
et al. A controlled study of adenoviral-vector-mediated gene transfer in the
nasal epithelium of patients with cystic fibrosis. N Engl J Med.1995;333:823-831.
Morgan JE. Cell and gene therapy in Duchenne muscular dystrophy. Hum Gene Ther.1994;5:165-173.
Grossman M, Raper SE, Kozarsky K.
et al. Successful ex vivo gene therapy directed to liver in a patient with
familial hypercholesterolaemia. Nat Genet.1994;6:335-341.
Vile RG, Russell SJ, Lemoine NR. Cancer gene therapy: hard lessons and new courses. Gene Ther.2000;7:2-8.
Chang MW, Barr E, Seltzer J.
et al. Cytostatic gene therapy for vascular proliferative disorders with a
constitutively active form of the retinoblastoma gene product. Science.1995;267:518-522.
Losordo DW, Vale PR, Symes JF.
et al. Gene therapy for myocardial angiogenesis: initial clinical results
with direct myocardial injection of phVEGF165 as sole therapy for myocardial
Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and
preliminary genomic organization of the DMD gene in normal and affected individuals. Cell.1987;50:509-517.
Davis CG, Lehrman MA, Russell DW, Anderson RG, Brown MS, Goldstein JL. The J.D. mutation in familial hypercholesterolemia: amino acid substitution
in cytoplasmic domain impedes internalization of LDL receptors. Cell.1986;45:15-24.
Friend SH, Bernards R, Rogelj S.
et al. A human DNA segment with properties of the gene that predisposes to
retinoblastoma and osteosarcoma. Nature.1986;323:643-646.
Miki Y, Swensen J, Shattuck-Eidens D.
et al. A strong candidate for the breast and ovarian cancer susceptibility
gene BRCA1. Science.1994;266:66-71.
Krieg AM, Yi AK, Matson S.
et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature.1995;374:546-549.
Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G.
et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science.2000;288:669-672.
Monahan PE, Samulski RJ. AAV vectors: is clinical success on the horizon? Gene Ther.2000;7:24-30.
Trono D. Lentiviral vectors: turning a deadly foe into a therapeutic agent. Gene Ther.2000;7:20-23.
Kay MA, Manno CS, Ragni MV.
et al. Evidence for gene transfer and expression of factor IX in haemophilia
B patients treated with an AAV vector. Nat Genet.2000;24:257-261.
Kasahara N, Dozy AM, Kan YW. Tissue-specific targeting of retroviral vectors through ligand-receptor
Roelvink PW, Mi Lee G, Einfeld DA, Kovesdi I, Wickham TJ. Identification of a conserved receptor-binding site on the fiber proteins
of CAR-recognizing adenoviridae. Science.1999;286:1568-1571.
Ye X, Rivera VM, Zoltick P.
et al. Regulated delivery of therapeutic proteins after in vivo somatic cell
gene transfer. Science.1999;283:88-91.
Bohl D, Naffakh N, Heard JM. Long-term control of erythropoietin secretion by doxycycline in mice
transplanted with engineered primary myoblasts. Nat Med.1997;3:299-305.
Binley K, Iqball S, Kingsman A, Kingsman S, Naylor S. An adenoviral vector regulated by hypoxia for the treatment of ischaemic
disease and cancer. Gene Ther.1999;6:1721-1727.
Marshall DJ, Palasis M, Lepore JJ, Leiden JM. Biocompatibility of cardiovascular gene delivery catheters with adenovirus
vectors: an important determinant of the efficiency of cardiovascular gene
transfer. Mol Ther.2000;1:423-429.
Not Available. Gene therapy's trials. Nature.2000;405:599.
Johansson CB, Momma S, Clarke DL, Risling M, Lendahl U, Frisen J. Identification of a neural stem cell in the adult mammalian central
nervous system. Cell.1999;96:25-34.
Morrison SJ, White PM, Zock C, Anderson DJ. Prospective identification, isolation by flow cytometry, and in vivo
self-renewal of multipotent mammalian neural crest stem cells. Cell.1999;96:737-749.
Doetsch F, Caille I, Lim DA, Garcia-Verdugo JM, Alvarez-Buylla A. Subventricular zone astrocytes are neural stem cells in the adult mammalian
Goldman SA, Nottebohm F. Neuronal production, migration, and differentiation in a vocal control
nucleus of the adult female canary brain. Proc Natl Acad Sci U S A.1983;80:2390-2394.
Gussoni E, Soneoka Y, Strickland CD.
et al. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature.1999;401:390-394.
Beauchamp JR, Morgan JE, Pagel CN, Partridge TA. Dynamics of myoblast transplantation reveal a discrete minority of
precursors with stem cell-like properties as the myogenic source. J Cell Biol.1999;144:1113-1122.
Bjornson CR, Rietze RL, Reynolds BA, Magli MC, Vescovi AL. Turning brain into blood: a hematopoietic fate adopted by adult neural
stem cells in vivo. Science.1999;283:534-537.
Ferrari G, Cusella-De Angelis G, Coletta M.
et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science.1998;279:1528-1530
[published erratum appears in Science. 1998;281:923].
Eglitis MA, Mezey E. Hematopoietic cells differentiate into both microglia and macroglia
in the brains of adult mice. Proc Natl Acad Sci U S A.1997;94:4080-4085.
Kopen GC, Prockop DJ, Phinney DG. Marrow stromal cells migrate throughout forebrain and cerebellum, and
they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci U S A.1999;96:10711-10716.
Petersen BE, Bowen WC, Patrene KD.
et al. Bone marrow as a potential source of hepatic oval cells. Science.1999;284:1168-1170.
Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH. Viable offspring derived from fetal and adult mammalian cells. Nature.1997;385:810-813 [published erratum appears in Nature. 1997;386:200].
Thomson JA, Itskovitz-Eldor J, Shapiro SS.
et al. Embryonic stem cell lines derived from human blastocysts. Science.1998;282:1145-1147 [published erratum appears in Science. 1998;282:1827].
Shamblott MJ, Axelman J, Wang S.
et al. Derivation of pluripotent stem cells from cultured human primordial
germ cells. Proc Natl Acad Sci U S A.1998;95:13726-13731 [published erratum appears in Proc Natl Acad Sci U S A. 1999;96:1162].
Nagy A, Rossant J, Nagy R, Abramow-Newerly W, Roder JC. Derivation of completely cell culture-derived mice from early-passage
embryonic stem cells. Proc Natl Acad Sci U S A.1993;90:8424-8428.
Brustle O, Jones KN, Learish RD.
et al. Embryonic stem cell-derived glial precursors: a source of myelinating
Barr E, Leiden JM. Systemic delivery of recombinant proteins by genetically modified myoblasts. Science.1991;254:1507-1509.
Perry D. Patients' voices: the powerful sound in the stem cell debate. Science.2000;287:1423.
Young FE. A time for restraint. Science.2000;287:1424.